Mark Jit
Mark Jit
Chair and Professor of the Department of Global and Environmental Health
-
Professional overview
-
Mark Jit is the inaugural chair and a professor in the Department of Global and Environmental Health. He was formerly head of the Department of Infectious Disease Epidemiology & Dynamics and co-director of the Global Health Economics Centre (GHECO) at the London School of Hygiene & Tropical Medicine (LSHTM). He holds honorary appointments at LSHTM as well as the University of Hong Kong (HKU) and the National University of Singapore (NUS).
Dr. Jit’s research focuses on epidemiological and economic modeling of vaccines to support evidence-based public health decision making. He has published papers covering a range of vaccine-preventable or potentially vaccine-preventable diseases including COVID-19, measles, HPV, pneumococcus, rotavirus, influenza, Group B Streptococcus, dengue, EV71 and RSV as well as methodological papers advancing the ways vaccines are evaluated. This work has influenced many of the major changes to immunization policy in countries around the world. Dr. Jit has served on a number of expert advisory committees in the UK as well as for international organizations such as the World Health Organization. He also organises or contributes to academic and professional courses on vaccine modeling, economics and decision science around the world.
Dr. Jit received his BSc and PhD in Mathematics from University College London, specializing in mathematical biology, and a Master of Public Health degree from King’s College London.
Visit Dr. Jit's Google Scholar's page to learn more about his research portfolio.
-
Education
-
BSc, Mathematics, University College LondonPhD, Mathematics, University College LondonMPH, Public Health, King's College London
-
Honors and awards
-
Clarivate Highly Cited Researcher (20222023)Fellow of the Academy of Medical Sciences (2023)Training Fund Award, Health Protection Agency (2007)Andrew Rosen Prize, University College London (1999)Institute of Mathematics and its Applications Award (1998)Departmental Research Studentship, University College London (1998)Student Union Commendation, University College London (1997)Fillon Prize, University College London (1996)Pathfinder Award, University College London (1995)
-
Publications
Publications
Recent economic evaluation of 1-dose HPV vaccination uses unsupported assumptions
Failed retrieving data.Reflections On Epidemiological Modeling To Inform Policy During The COVID-19 Pandemic In Western Europe, 2020–23
Failed retrieving data.Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7–8, 2022
Failed retrieving data.The age profile of respiratory syncytial virus burden in preschool children of low- and middle-income countries : A semi-parametric, meta-regression approach
Failed retrieving data.The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries : A modeling study
Failed retrieving data.The effectiveness of pay-it-forward in addressing HPV vaccine delay and increasing uptake among 15–18-year-old adolescent girls compared to user-paid vaccination : a study protocol for a two-arm randomized controlled trial in China
Failed retrieving data.The Full Value of Vaccine Assessments (FVVA) : a framework for assessing and communicating the value of vaccines for investment and introduction decision-making
Failed retrieving data.The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries : a modelling study
Failed retrieving data.The need and ongoing efforts to understand the full value of improved influenza vaccines
Failed retrieving data.The potential cost-effectiveness of next generation influenza vaccines in England and Wales : A modelling analysis
Failed retrieving data.The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries : A modeling study
Failed retrieving data.The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study
Failed retrieving data.The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries
Failed retrieving data.Transplacental transfer efficiency of maternal antibodies against influenza A(H1N1)pdm09 virus and dynamics of naturally acquired antibodies in Chinese children : a longitudinal, paired mother–neonate cohort study
Failed retrieving data.Using Age-Specific Values for Pediatric HRQoL in Cost-Effectiveness Analysis : Is There a Problem to Be Solved? If So, How?
Failed retrieving data.Vaccine Value Profiles
Failed retrieving data.Value profile for respiratory syncytial virus vaccines and monoclonal antibodies
Failed retrieving data.What are economic costs and when should they be used in health economic studies?
Failed retrieving data.What are economic costs and when should they be used in health economic studies?
Failed retrieving data.What, how and who : Cost-effectiveness analyses of COVID-19 vaccination to inform key policies in Nigeria
Failed retrieving data.What, how and who: Cost-effectiveness analyses of COVID-19 vaccination to inform key policies in Nigeria
Failed retrieving data.“We usually see a lot of delay in terms of coming for or seeking care” : an expert consultation on COVID testing and care pathways in seven low- and middle-income countries
Failed retrieving data.A global assessment of the impact of school closure in reducing COVID-19 spread
Failed retrieving data.Changes in social contacts in England during the COVID-19 pandemic between March 2020 and March 2021 as measured by the CoMix survey : A repeated cross-sectional study
Failed retrieving data.Comparative assessment of methods for short-term forecasts of COVID-19 hospital admissions in England at the local level
Failed retrieving data.